茚达特罗在慢性阻塞性肺病COPD治疗中的价值-Journalof.PDF

Review Article 茚达特罗在慢性阻塞性肺病(COPD) 治疗中的价值 Mario Cazzola, Floriana Bardaro, Emanuele Stirpe Unit of Respiratory Clinical Pharmacology, Department of System Medicine, University of Rome “Tor Vergata”, Rome, Italy Corresponding to: Prof. Mario Cazzola. Unità di Farmacologia Clinica Respiratoria, Dipartimento di Medicina dei Sistemi, Università di Roma “Tor Vergata”, Via Montpellier 1, 00133 Rome, Italy. Email: mario.cazzola@uniroma2.it. β 摘要: 茚达特罗是首个批准用于慢性阻塞性肺病(COPD)治疗的长效 2-激动剂(LABAs) ，该药物允许每日服药 一次(OD)。